Trial intelligence / Profile preview

NER1006 for Bowel Cleansing (NOCT)

NCT02254486Phase 3Completed

Sponsor
Norgine
Start
Sep 2014
Primary completion
Jun 2015
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of polyethylene glycol + electrolytes + ascorbic acid, sponsored by Norgine. Primary endpoint: Number of Patients With Successful Bowel Cleansing (Overall Colon) at 2 days. Started Sep 2014; status: completed.

02

Drugs

polyethylene glycol + electrolytes + ascorbic acid

Beyond the preview

Go deeper on NCT02254486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02254486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call